Table of Contents Author Guidelines Submit a Manuscript
Neurology Research International
Volume 2017, Article ID 2985729, 5 pages
https://doi.org/10.1155/2017/2985729
Research Article

Report from a Survey of Parents Regarding the Use of Cannabidiol (Medicinal cannabis) in Mexican Children with Refractory Epilepsy

Instituto Tecnológico de Estudios Superiores de Monterrey, Campus Salud, Avenida Morones Prieto 3000 Pte., Col. Los Doctores, 64710 Monterrey, NL, Mexico

Correspondence should be addressed to Carlos G. Aguirre-Velázquez; moc.liamtoh@erriugacrd

Received 26 October 2016; Revised 14 December 2016; Accepted 15 December 2016; Published 14 March 2017

Academic Editor: Vincenzo Di Lazzaro

Copyright © 2017 Carlos G. Aguirre-Velázquez. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. World Health Organization, “Mental health, neurology, epileps,” 2012, http://www.who.int/mental_health/neurology/epilepsy.
  2. P. Kwan, A. Arzimanoglou, A. T. Berg et al., “Definition of drug resistant epilepsy: consensus proposal by the ad hoc task force of the ILAE commission on therapeutic strategies,” Epilepsia, vol. 51, no. 6, pp. 1069–1077, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. D. F. Rubio, “Aspectos generales y clasificación de la epilepsia,” in Epilepsia, D. F. Rubio, Ed., pp. 1–23, Ediciones del Instituto Nacional de Neurología y Neurocirugía, México City, México, 1st edition, 1997. View at Google Scholar
  4. J. Serrano-Martín, “Aspectos Epidemiológicos de la Epilepsia en un Hospital de General de Segundo Nivel,” Plasticidad y Restauración Neurológica, vol. 3, no. 1-2, pp. 39–43, 2004. View at Google Scholar
  5. J. W. Wheless, “Managing severe epilepsy syndromes of early childhood,” Journal of Child Neurology, vol. 24, no. 8, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. R. Mechoulam, A. Shani, H. Edery, and Y. Grunfeld, “Chemical basis of hashish activity,” Science, vol. 169, no. 3945, pp. 611–612, 1970. View at Publisher · View at Google Scholar · View at Scopus
  7. A. A. Izzo, F. Borrelli, R. Capasso, V. Di Marzo, and R. Mechoulam, “Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb,” Trends in Pharmacological Sciences, vol. 30, no. 10, pp. 515–527, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Gupta, “It's time for a medical marijuana revolution,” http://edition.cnn.com/2015/04/16/opinions/medical-marijuana-revolution-sanjay-gupta/index.html.
  9. G. Mathern, A. Nehlig, and M. Sperling, “Cannabidiol and medical marijuana for the treatment of epilepsy,” Epilepsia, vol. 55, no. 6, pp. 781–782, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. D. Gloss and B. Vickrey, “Cannabinoids for epilepsy,” Cochrane database of systematic reviews, vol. 6, Article ID CD009270, 2012. View at Google Scholar · View at Scopus
  11. B. E. Porter and C. Jacobson, “Report of a parent survey of cannabidiol-enriched cannabis use in pediatric treatment-resistant epilepsy,” Epilepsy and Behavior, vol. 29, no. 3, pp. 574–577, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. S. A. Hussain, R. Zhou, C. Jacobson et al., “Perceived efficacy of cannabidiol-enriched cannabis extracts for treatment of pediatric epilepsy: a potential role for infantile spasms and Lennox-Gastaut syndrome,” Epilepsy & Behavior, vol. 47, pp. 138–141, 2015. View at Publisher · View at Google Scholar · View at Scopus
  13. O. Devinsky, E. Marsh, D. Friedman et al., “Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial,” The Lancet. Neurology, vol. 15, no. 3, pp. 270–278, 2016. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Kalkach-Aparicio, M. Cuéllar-Herrera, E. L. Flores-Ramírez et al., “The use of cannabis as an antiepileptic treatment in Mexico: a review, bioethical analysis, discussion and position of the Hospital General de México Epilepsy Clinic,” Revista Médica del Hospital General de México, vol. 79, no. 2, pp. 68–78, 2016. View at Publisher · View at Google Scholar
  15. V. M. Rivera-Olmos and M. Parra-Bernal, “Cannabis: efectos en el sistema nervioso central. Consecuencias terapéuticas, sociales y legales,” Revista Médica del Instituto Mexicano del Seguro Social, vol. 54, no. 5, pp. 626–634, 2016. View at Google Scholar